Investing in women’s health research, innovation, and services is crucial for the well-being of society as a whole. Yet although women make up over half the U.S. population, a disproportionately small percentage of health and medical research is dedicated to female-specific conditions other than cancer. Following the overturning of Roe v. Wade, the U.S. landscape of family planning and reproductive care is in flux—as is the way women access and pay for needed health care services. This is happening amidst a troubling trend that now sees U.S. maternal mortality 10 times higher than other OECD countries—and 20 times higher for Black women. In an era when companies increasingly make pledges toward social causes, will women's reproductive health care—an issue that affects us all and has a clear and direct impact on an organization’s success—see similar support? How can we raise awareness and mobilize broader support for investment in women’s reproductive health?